Similar articles for PMID: 31451486

Year	Number of Results
1989	1
1991	1
1993	1
1995	2
1997	1
1998	1
1999	1
2000	4
2001	2
2003	1
2004	2
2005	4
2006	2
2007	6
2008	8
2009	4
2010	4
2011	5
2012	12
2013	8
2014	5
2015	9
2016	9
2017	7
2018	2
2019	3
2020	4
2022	4
2023	2
2024	0

1

¹³¹I-IITM and ²¹¹At-AITM: Two Novel Small-Molecule Radiopharmaceuticals Targeting Oncoprotein Metabotropic Glutamate Receptor 1.

Xie L, Hanyu M, Fujinaga M, Zhang Y, Hu K, Minegishi K, Jiang C, Kurosawa F, Morokoshi Y, Li HK, Hasegawa S, Nagatsu K, Zhang MR. Xie L, et al. J Nucl Med. 2020 Feb;61(2):242-248. doi: 10.2967/jnumed.119.230946. Epub 2019 Aug 26. J Nucl Med. 2020. PMID: 31451486 Free PMC article.

2

A ²¹¹At-labelled mGluR1 inhibitor induces cancer senescence to elicit long-lasting anti-tumor efficacy.

Xie L, Zhang L, Hu K, Hanyu M, Zhang Y, Fujinaga M, Minegishi K, Ohkubo T, Nagatsu K, Jiang C, Shimokawa T, Ashisuke K, Okonogi N, Yamada S, Wang F, Wang R, Zhang MR. Xie L, et al. Cell Rep Med. 2023 Apr 18;4(4):100960. doi: 10.1016/j.xcrm.2023.100960. Epub 2023 Mar 31. Cell Rep Med. 2023. PMID: 37003259 Free PMC article.

3

Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain.

Fujinaga M, Yamasaki T, Yui J, Hatori A, Xie L, Kawamura K, Asagawa C, Kumata K, Yoshida Y, Ogawa M, Nengaki N, Fukumura T, Zhang MR. Fujinaga M, et al. J Med Chem. 2012 Mar 8;55(5):2342-52. doi: 10.1021/jm201590g. Epub 2012 Feb 24. J Med Chem. 2012. PMID: 22316010

4

[carbonyl-11C]4-Fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([11C]FIMX) is an effective radioligand for PET imaging of metabotropic glutamate receptor 1 (mGluR1) in monkey brain.

Hong J, Lu S, Xu R, Liow JS, Woock AE, Jenko KJ, Gladding RL, Zoghbi SS, Innis RB, Pike VW. Hong J, et al. Nucl Med Biol. 2015 Dec;42(12):967-74. doi: 10.1016/j.nucmedbio.2015.07.006. Epub 2015 Jul 23. Nucl Med Biol. 2015. PMID: 26320813 Free PMC article.

5

Synthesis and evaluation of 4-halogeno-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-[11C]methylbenzamide for imaging of metabotropic glutamate 1 receptor in melanoma.

Fujinaga M, Xie L, Yamasaki T, Yui J, Shimoda Y, Hatori A, Kumata K, Zhang Y, Nengaki N, Kawamura K, Zhang MR. Fujinaga M, et al. J Med Chem. 2015 Feb 12;58(3):1513-23. doi: 10.1021/jm501845n. Epub 2015 Jan 30. J Med Chem. 2015. PMID: 25602363

6

Molecular imaging of ectopic metabotropic glutamate 1 receptor in melanoma with a positron emission tomography radioprobe (18) F-FITM.

Xie L, Yui J, Fujinaga M, Hatori A, Yamasaki T, Kumata K, Wakizaka H, Furutsuka K, Takei M, Jin ZH, Furukawa T, Kawamura K, Zhang MR. Xie L, et al. Int J Cancer. 2014 Oct 15;135(8):1852-9. doi: 10.1002/ijc.28842. Epub 2014 Mar 19. Int J Cancer. 2014. PMID: 24643962 Free article.

7

Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist.

Satoh A, Nagatomi Y, Hirata Y, Ito S, Suzuki G, Kimura T, Maehara S, Hikichi H, Satow A, Hata M, Ohta H, Kawamoto H. Satoh A, et al. Bioorg Med Chem Lett. 2009 Sep 15;19(18):5464-8. doi: 10.1016/j.bmcl.2009.07.097. Epub 2009 Jul 23. Bioorg Med Chem Lett. 2009. PMID: 19674894

8

Preclinical and the first clinical studies on [11C]ITMM for mapping metabotropic glutamate receptor subtype 1 by positron emission tomography.

Toyohara J, Sakata M, Fujinaga M, Yamasaki T, Oda K, Ishii K, Zhang MR, Moriguchi Jeckel CM, Ishiwata K. Toyohara J, et al. Nucl Med Biol. 2013 Feb;40(2):214-20. doi: 10.1016/j.nucmedbio.2012.11.008. Epub 2012 Dec 21. Nucl Med Biol. 2013. PMID: 23265669

9

Radiosynthesis and preliminary evaluation of 4-[18F]fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as a new positron emission tomography ligand for metabotropic glutamate receptor subtype 1.

Yamasaki T, Fujinaga M, Yoshida Y, Kumata K, Yui J, Kawamura K, Hatori A, Fukumura T, Zhang MR. Yamasaki T, et al. Bioorg Med Chem Lett. 2011 May 15;21(10):2998-3001. doi: 10.1016/j.bmcl.2011.03.046. Epub 2011 Mar 17. Bioorg Med Chem Lett. 2011. PMID: 21470858

10

Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.

Mier W, Kratochwil C, Hassel JC, Giesel FL, Beijer B, Babich JW, Friebe M, Eisenhut M, Enk A, Haberkorn U. Mier W, et al. J Nucl Med. 2014 Jan;55(1):9-14. doi: 10.2967/jnumed.112.112789. Epub 2013 Nov 25. J Nucl Med. 2014. PMID: 24277756 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year